The fibril forming region of the beta-amyloid precursor differs from that of the amyloid A precursor in its interaction with lipids

被引:7
作者
Liang, JS
Fine, RE
Abraham, CR
Sipe, JD
机构
[1] BOSTON UNIV, SCH MED, DEPT BIOCHEM, BOSTON, MA 02118 USA
[2] BOSTON UNIV, SCH MED, CTR ARTHRITIS, BOSTON, MA 02118 USA
[3] VET ADM MED CTR, ENR, BEDFORD, MA 01730 USA
关键词
D O I
10.1006/bbrc.1996.0332
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Since the amyloid A (AA) precursor, serum amyloid A (apoSAA), has been shown to bind cholesterol (C) in the AA fibril forming region, we investigated the interaction of the beta-amyloid precursor protein (A beta PP) and beta-amyloid (A beta) peptide with C and phosphatidyl choline (PC) by measuring changes in binding to microtiter wells at physiological pH and ionic strength. While either C or PC inhibited A beta PP binding to the same extent that C inhibited apoSAA binding, neither C nor PC had any effect on binding of the A beta peptide, although antibodies to A beta 1-40 did block binding. The binding of I-125-A beta 1-40 and 125I-A beta PP was inhibited by apoE3 and apoE4, but not by either apoSAA or bovine serum albumin. Bound I-125-A beta PP was partially released into medium containing C, PC, apoE3, apoE4, or antibodies to A beta PP. Our results indicate that A beta PP but not A beta peptide can be retained in solution in the presence of C and PC and suggest that this failure to interact with lipids may account for the greater insolubility of A beta fibrils than AA Fibrils. (C) 1996 Academic Press, Inc.
引用
收藏
页码:962 / 967
页数:6
相关论文
共 23 条
  • [1] ANDERSON JP, 1992, J NEUROCHEM, V59, P2328
  • [2] CLEAVAGE OF AMYLOID-BETA PEPTIDE DURING CONSTITUTIVE PROCESSING OF ITS PRECURSOR
    ESCH, FS
    KEIM, PS
    BEATTIE, EC
    BLACHER, RW
    CULWELL, AR
    OLTERSDORF, T
    MCCLURE, D
    WARD, PJ
    [J]. SCIENCE, 1990, 248 (4959) : 1122 - 1124
  • [3] EVANS KC, 1995, BIOCHEMISTRY-US, V92, P763
  • [4] ALZHEIMERS-DISEASE - INITIAL REPORT OF THE PURIFICATION AND CHARACTERIZATION OF A NOVEL CEREBROVASCULAR AMYLOID PROTEIN
    GLENNER, GG
    WONG, CW
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (03) : 885 - 890
  • [5] KIM KS, 1990, NEUROSCI RES COMMUN, V7, P113
  • [6] APOLIPOPROTEIN-E GENOTYPES IN AA AND AL AMYLOIDOSES
    KINDY, MS
    DEBEER, FC
    MARKESBERY, WR
    PRAS, M
    AKSENTIJEVICH, I
    KASTNER, D
    KYLE, R
    SOLOMON, A
    WOO, P
    [J]. AMYLOID-INTERNATIONAL JOURNAL OF EXPERIMENTAL AND CLINICAL INVESTIGATION, 1995, 2 (03): : 159 - 162
  • [7] LADU MJ, 1994, J BIOL CHEM, V269, P23403
  • [8] PURIFICATION OF APOLIPOPROTEIN-E ATTENUATES ISOFORM-SPECIFIC BINDING TO BETA-AMYLOID
    LADU, MJ
    PEDERSON, TM
    FRAIL, DE
    REARDON, CA
    GETZ, GS
    FALDUTO, MT
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (16) : 9039 - 9042
  • [9] LIANG JS, 1995, J LIPID RES, V36, P37
  • [10] APOLIPOPROTEIN E4 GENOTYPE IS NOT A RISK FACTOR FOR SYSTEMIC AA AMYLOIDOSIS OR FAMILIAL AMYLOID POLYNEUROPATHY
    LOVAT, LB
    BOOTH, SE
    BOOTH, DR
    MADHOO, S
    HOLMGREN, G
    HAWKINS, PN
    SOUTAR, AK
    PEPYS, MB
    [J]. AMYLOID-INTERNATIONAL JOURNAL OF EXPERIMENTAL AND CLINICAL INVESTIGATION, 1995, 2 (03): : 163 - 166